Tower Trust & Investment Company’s Accelerate Diagnostics AXDX Stock Holding History

Tower Trust & Investment Company’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-140	Closed	-$72	–	194
2025 Q1	$72	Buy	+140	New	+$160	﹤0.01%	195

Other funds holding AXDX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Tower Trust & Investment Company's AXDX Position: Q2 2025 in Review

Tower Trust & Investment Company sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 140 shares — an estimated $72 sold.

Tower Trust & Investment Company first reported a position in AXDX in Q1 2025 and held it in 1 quarter. The position peaked at $72 in Q1 2025. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

Tower Trust & Investment Company reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
Tower Trust & Investment Company sold 140 Accelerate Diagnostics shares in Q2 2025, an estimated $72.
Tower Trust & Investment Company first reported a position in Accelerate Diagnostics in Q1 2025 and held it in 1 quarter.
Tower Trust & Investment Company's Accelerate Diagnostics position peaked at $72 in Q1 2025.
3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Tower Trust & Investment Company's 13F filing for Q2 2025, filed 16 Jul 2025.